Zhong Lab News
March 20th, 2023 |
|
March 13th, 2023 |
Zhong Lab website is live. Thank you so much to Justine Pinskey (Sr. Scientific Writer – Office of Health Equity), a wonderful person who helped set up, design, edit, and launch this site. Cheers! |
February 20th, 2023 |
Madhu Suresh, Research Associate III, joined the lab. Welcome Madhu! |
February 12th, 2023 | Zhong Lab manuscript entitled “Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infection” was submitted for peer view. Congratulations to Mengjia Lu, Weitong Yao, Yujun Li, and Danting Ma, equal first authors of this manuscript & former lab members of Zhong Lab before we started at UMass Chan. |
November 22nd, 2022 |
|
August 22nd, 2022 |
Zhong Lab former lab member Xiaojuan Tang passed her Ph.D. Qualifying Exam at Peking University Shenzhen Graduate School and decided to rejoin Zhong Lab at UMass Chan as a J-1 visiting student. Welcome Xiaojuan in advance! |
August 21st, 2022 | The Future Science Prize committee announced Dr. Wenhui Li as the laureate 2022 Future Science Prize – The Life Science Prize (1 million US dollars to the prize laureate) for the discovery of sodium taurocholate cotransporting polypeptide (NTCP) as a receptor for HBV and HDV infection. Guocai was one of two equal first authors of the original paper reporting this discovery in 2012. The Future Science Prize committee’s comments on this discovery: “This is a milestone breakthrough in HBV research in the past three decades. The discovery uncovers a key molecular mechanism in HBV and HDV infection. This discovery facilitates the development of more effective treatment for hepatitis B and D.” Cheers! |
July 5th, 2022 |
Haimin Wang, Sr. Research Scientist, joined the lab. Welcome Haimin! |
July 1st, 2022 |
Zhong Lab officially started at UMass Chan. |
![]() |
|
February 9th, 2021 |
|
November 12th, 2020 |
Hepatitis B Foundation announced Dr. Wenhui Li as the recipient of 2021 Baruch S. Blumberg Prize, the highest honor for hepatitis B research, for the discovery of sodium taurocholate cotransporting polypeptide (NTCP) as a receptor for HBV and HDV infection. Guocai was one of two equal first authors of the original paper reporting this discovery in 2012. |
December 26th, 2019 |
Guocai’s RNA switch study went onto the front page of the Scripps Research Institute website. Cheers! Click here to learn more about our original publication. |
|
|